SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001038133-22-000018
Filing Date
2022-05-05
Accepted
2022-05-05 17:24:32
Documents
12
Period of Report
2022-05-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K hska-20220504.htm   iXBRL 8-K 65464
  Complete submission text file 0001038133-22-000018.txt   210970

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hska-20220504.xsd EX-101.SCH 1894
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hska-20220504_lab.xml EX-101.LAB 23832
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hska-20220504_pre.xml EX-101.PRE 12506
6 EXTRACTED XBRL INSTANCE DOCUMENT hska-20220504_htm.xml XML 19243
Mailing Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538
Business Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538 9704937272
HESKA CORP (Filer) CIK: 0001038133 (see all company filings)

IRS No.: 770192527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22427 | Film No.: 22897827
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences